Veralto Announces Acquisition of GlobalVision and the Completion of $300 Million of Share Repurchases

Rhea-AI Summary

Veralto (NYSE: VLTO) announced it will acquire GlobalVision and completed approximately $300 million of share repurchases in Q1 2026. GlobalVision is expected to deliver ~$25 million in 2026 sales with ~85% recurring revenue and ~30% adjusted EBITDA margin.

The purchase price is ~15x estimated adjusted EBITDA of $13 million; the deal is neutral to adjusted EPS in 2026 and accretive in 2027, with ROIC expected to exceed WACC by year three.

Positive

• 2026 sales of ~ $25 million with 85% recurring revenue
• Adjusted EBITDA margin of ~ 30% on a standalone basis (2026)
• Acquisition projected to be accretive to adjusted EPS in 2027
• Completed $300 million share repurchase (3.2 million shares, ~1.3% outstanding)

Negative

• Purchase price of approximately 15x estimated adjusted EBITDA ($13 million)
• Deal is neutral to adjusted EPS in 2026, delaying immediate EPS upside

News Market Reaction – VLTO

+2.80%

+2.80% Session close to close

In the Mar 31 session, VLTO gained 2.80%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement combines a bolt-on acquisition and meaningful capital return. Veralto plans to buy...

Analysis

This announcement combines a bolt-on acquisition and meaningful capital return. Veralto plans to buy GlobalVision, which is expected to generate about $25M of 2026 sales, roughly 85% recurring, with an adjusted EBITDA margin near 30%. The company also repurchased roughly 3.2M shares for about $300M in Q1 2026. Investors may track how the 15x EBITDA valuation, targeted cost synergies, and integration into Esko affect margins and future cash allocation.

Key Figures

GlobalVision 2026 sales: $25 million Recurring revenue mix: 85% Adj. EBITDA margin: 30% +5 more

8 metrics

GlobalVision 2026 sales $25 million Expected 2026 sales for acquired business

Recurring revenue mix 85% Portion of GlobalVision 2026 sales on recurring basis

Adj. EBITDA margin 30% GlobalVision 2026 standalone adjusted EBITDA margin, excl. deal costs

Sales CAGR 19% GlobalVision compound annual sales growth since 2023

Purchase multiple 15x Purchase price vs estimated 2026 adjusted EBITDA of $13M

GlobalVision EBITDA $13 million Estimated 2026 adjusted EBITDA including cost synergies by year two

Shares repurchased 3.2 million VLTO common shares repurchased in Q1 2026

Buyback value $300 million Total spend on Q1 2026 share repurchases (~1.3% of shares)

Previous Buybacks,acquisition Reports

1 past event · Latest: Nov 25 (Positive)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 25	Acquisition & buyback	Positive	+5.9%	In-Situ acquisition plus new $750M share repurchase authorization.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited but prior buyback-plus-acquisition news for VLTO coincided with a positive single-day share reaction.

Recent Company History

This announcement continues Veralto’s strategy of combining M&A with shareholder returns. In November 2025, VLTO agreed to acquire In-Situ and simultaneously authorized a $750M buyback, and the stock rose 5.93% the next day. Since then, the company has reported solid 2025 results with $5.503B sales and strong free cash flow while initiating and increasing dividends. Today’s GlobalVision acquisition and Q1 $300M repurchase fit that pattern of disciplined capital deployment.

Key Terms

compound annual growth rate, adjusted ebitda, return on invested capital, weighted average cost of capital, +4 more

8 terms

compound annual growth rate financial

"Since 2023, GlobalVision has grown sales at a compound annual growth rate of approximately 19%"

The compound annual growth rate (CAGR) shows how much an investment or value has grown, on average, each year over a specific period. It considers the effect of growth that compounds or builds upon itself, similar to how interest accumulates in a savings account. Investors use CAGR to compare different investments’ long-term performance and to understand how steady or consistent their growth has been over time.

adjusted ebitda financial

"GlobalVision's 2026 adjusted EBITDA margin is expected to be approximately 30%"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

return on invested capital financial

"By year three, the return on invested capital is expected to exceed the Company's weighted average cost of capital."

A percentage that shows how effectively a company turns the money invested in its business—both borrowed funds and shareholders’ equity—into operating profit after taxes. It tells investors whether a company earns more from its core operations than it costs to fund those operations; think of it like the annual return you’d expect from renovating a rental property—higher percentages mean the company uses capital more efficiently and is more likely to create value for shareholders.

weighted average cost of capital financial

"return on invested capital is expected to exceed the Company's weighted average cost of capital."

Weighted average cost of capital (WACC) is the average annual price a company pays for the money it uses, combining the cost of borrowed funds (debt) and the cost of owners’ funds (equity), with each source weighted by its share of the company’s financing. Investors use it as a benchmark to judge whether projects or a stock are likely to earn more than that blended price—think of it as a household’s combined interest rate on a mortgage and credit cards; a lower WACC usually makes future cash flows and valuation more attractive.

cost synergies financial

"plus cost synergies expected to be achieved by the end of year two."

Cost synergies are the expected savings when two businesses combine activities so they can eliminate duplicate work, negotiate better prices, or run things more efficiently—like two households moving in together to share rent, groceries and utilities. Investors care because these savings can boost profit margins and cash flow, improving returns and supporting a higher valuation if the projected cuts are realistic and actually achieved. Actual results may differ from projections, so promised cost synergies are closely watched in deal assessments.

rule 144 regulatory

"notice of proposed sale under Rule 144 for 10,000 shares"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

View in glossary

schedule 13g/a regulatory

"filed Amendment No. 4 to a Schedule 13G/A reporting 0 shares beneficially owned"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

free cash flow financial

"free cash flow exceeded $1 billion."

Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Combines a long-term strategic partner; synergistic bolt-on with complementary portfolio
• Strengthens Esko's source-to-shelf digital workflow solutions for packaging design
• Demonstrates disciplined and balanced approach to capital allocation

WALTHAM, Mass., March 31, 2026 /PRNewswire/ -- Veralto (NYSE: VLTO) (the "Company"), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital Resources™, announced it has entered into a definitive agreement to acquire GlobalVision, subject to customary closing conditions.

GlobalVision, headquartered in Montreal, leverages its core proprietary deterministic technology with AI-augmented functionality to help pharmaceutical and consumer packaged goods customers accelerate their speed to market and meet critical quality and packaging compliance regulations, verifying that packaging content remains accurate and compliant at every critical hand-off.

GlobalVision will be integrated into the Company's Esko business, building on their decade‑long partnership and embedding an AI‑augmented quality and compliance backbone directly into Esko's end‑to‑end, source‑to‑shelf packaging platform.

"Consumer packaged goods and pharmaceutical companies are facing incredible demands to meet regulatory and brand consistency standards as they introduce new products to market quickly and accurately," said Jennifer L. Honeycutt, President and Chief Executive Officer, Veralto. "Embedding GlobalVision's core technology into Esko's workflow solutions will help our customers get products to market faster and avoid costly errors by ensuring packaging is accurate and compliant."

"We've spent decades building GlobalVision to ensure that the most critical packaging content in the world is accurate, compliant, and trusted," said Brandon Malz, Chief Executive Officer, GlobalVision. "Joining Esko and Veralto is a natural next step — it allows us to embed that capability directly into the packaging lifecycle at global scale. Together, we see a unique opportunity to bring AI-augmented quality and compliance deeper into our customers' workflows and fundamentally transform how products are brought to market."

Financial Information
Since 2023, GlobalVision has grown sales at a compound annual growth rate of approximately 19% with expected future sales growth in the mid-teens.

In 2026, GlobalVision is expected to deliver approximately $25 million in sales, with approximately 85% on a recurring basis. On a standalone basis, GlobalVision's 2026 adjusted EBITDA margin is expected to be approximately 30%, excluding deal related costs. The acquisition is expected to be neutral to Veralto's adjusted EPS in 2026 and accretive to adjusted EPS in 2027. 

The purchase price is approximately 15x estimated adjusted EBITDA of $13 million, which is comprised of 2026 estimated standalone adjusted EBITDA plus cost synergies expected to be achieved by the end of year two. By year three, the return on invested capital is expected to exceed the Company's weighted average cost of capital.

Veralto's management team will provide more details on the acquisition when it reports its first quarter 2026 results.

Share Repurchase Update
In the first quarter of 2026, the Company repurchased approximately 3.2 million shares of Veralto common stock for about $300 million. This represents approximately 1.3% of the Company's outstanding shares as of February 13, 2026.

About Veralto
With annual sales of approximately $5.5 billion, Veralto is a global leader in essential technology solutions with a proven track record of solving some of the most complex challenges we face as a society. Our industry-leading companies with globally recognized brands help billions of people around the world access clean water, safe food and trusted essential goods. Headquartered in Waltham, Massachusetts, our global team of about 17,000 associates is committed to making an enduring positive impact on our world and united by a powerful purpose: Safeguarding the World's Most Vital Resources™.

About GlobalVision
Founded in 1990, GlobalVision has spent over 36 years pioneering technology designed to eliminate packaging and labeling errors and streamline quality control. Its mission is to empower regulated industries to develop and approve assets at scale without compromising on quality or compliance. Trusted by thousands of organizations in over 100 countries, GlobalVision's technology provides AI-augmented inspections for text, graphics, barcodes, QR codes, color, and braille. By catching errors instantly across both digital and printed assets, it helps life sciences, CPG companies, their premedia and packaging partners, and print and packaging suppliers eliminate errors and maintain total regulatory adherence – all while getting products to market faster.

Use of Non-GAAP Financial Information
Veralto supplements its consolidated financial statements presented on a GAAP basis with certain non-GAAP financial information, to provide investors with greater insight, increase transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. References to non-GAAP core sales refer to sales calculated according to GAAP but excluding sales from acquired (or divested) businesses and the impact of currency translation. References to non-GAAP adjusted EBITDA margin refer to earnings before interest, taxes, depreciation and amortization expenses, adjusted for unusual, infrequent, or non-recurring items that are not considered part of core ongoing operations by management divided by sales. References to the non-GAAP financial measure of return on invested capital refers to the gross purchase price of the acquisition divided by the net operating profit after taxes of the acquired business. References to non-GAAP diluted adjusted EPS refer to earnings adjusted for unusual, infrequent, or non-recurring items that are not considered part of core ongoing operations by management per diluted common share. The non-GAAP financial measures disclosed by Veralto in this press release should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP, and the financial results prepared in accordance with GAAP and reconciliations from these results should be carefully evaluated.

GlobalVision Financial Information
The financial information of GlobalVision provided herein is unaudited and is derived from information provided to Veralto by GlobalVision's management in conjunction with due diligence procedures, with various Veralto management adjustments also reflected. This information has not been conformed to the accounting principles (GAAP) and accounting policies followed by Veralto. Further, the definitions of performance measures of the GlobalVision business, such as sales, gross margin and operating profit, may not align with the definition of Veralto.

Forward-Looking Statements
Certain statements in this release, including the statements regarding the proposed acquisition of GlobalVision and the anticipated timing thereof, the anticipated impact of the transaction on the Company, GlobalVision's future financial performance, the Company's share repurchase program, the Company's differentiation and positioning to continue delivering sustainable, long-term shareholder value and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. All statements other than historical factual information are forward-looking statements, including, without limitation, statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, Veralto's liquidity position or other financial measures; Veralto's management's plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spin-offs, split-offs or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets Veralto sells into, including the impact of changes to global trade policies, restrictions on imports, related countermeasures and reciprocal tariffs; future new or modified laws, regulations and accounting pronouncements or public policy changes; future regulatory approvals and the timing thereof; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Veralto intends or believes will or may occur in the future. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/veralto-announces-acquisition-of-globalvision-and-the-completion-of-300-million-of-share-repurchases-302729374.html

SOURCE Veralto

FAQ

What did Veralto (VLTO) announce on March 31, 2026 about GlobalVision?

Veralto announced it agreed to acquire GlobalVision and integrate it into Esko's business. According to the company, GlobalVision is expected to deliver about $25 million in 2026 sales with ~85% recurring revenue and ~30% adjusted EBITDA margin.

How much did Veralto (VLTO) spend on share repurchases in Q1 2026?

Veralto repurchased approximately 3.2 million shares for about $300 million in Q1 2026. According to the company, this represents roughly 1.3% of outstanding shares as of February 13, 2026.

What valuation multiple did Veralto (VLTO) pay for GlobalVision?

The purchase price is about 15x estimated adjusted EBITDA of $13 million. According to the company, that multiple includes expected cost synergies to be achieved by the end of year two.

Will the GlobalVision acquisition impact Veralto's earnings per share (EPS)?

The acquisition is forecast to be neutral to adjusted EPS in 2026 and accretive in 2027. According to the company, accruals and synergies drive the expected EPS accretion in 2027.

What are GlobalVision's margins and recurring revenue profile in 2026?

GlobalVision is expected to report ~30% adjusted EBITDA margin in 2026 and about 85% of sales recurring. According to the company, these metrics underpin the deal's strategic fit with Esko's workflow solutions.

When will Veralto provide more details about the GlobalVision acquisition and finances?

Veralto will provide additional details when it reports first quarter 2026 results. According to the company, management will discuss acquisition impact, integration plans, and updated financial metrics at that time.